Announcement on Abnormal Fluctuations in Stock Trading
Filed with SSE · · 3 pages · Chinese
Shanghai Medicilon, Inc. on 6ix
Earlier from Shanghai Medicilon
- Announcement on Progress in Repurchasing Shares through Call Auction
- Announcement on Equity Change of Shareholders Reaching 1% and Results of Shareholding Reduction
- Medicilon Passes FDA Inspection, Reinforcing Global R&D Excellence
- Announcement on Repurchasing 1% Shares through Call Auction and Progress in Repurchasing Shares
- Announcement on Resolution of the 2024 Annual General Meeting
Later from Shanghai Medicilon
- Announcement on Implementation Results of Share Repurchase and Share Changes
- Announcement on Resolutions of the 5th Meeting of the 4th Board of Supervisors
- Special Report on Semi-annual Deposit, Management and Actual Use of Raised Funds in 2025
- Announcement on Litigation Involving Subsidiary
- Announcement on Attending Collective Performance Briefing for Innovative Drug Industry on Semi-annual SSE STAR Market 2025
Follow Shanghai Medicilon into a list and get an email when it puts out news.
Follow Shanghai Medicilon